Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy

https://doi.org/10.1016/S0002-9394(14)75794-0Get rights and content

The vitreous levels of the angiogenic polypeptide vascular endothelial growth factor (also known as vascular permeability factor) were measured and compared in eyes with and without proliferative diabetic retinopathy. Undiluted vitreous samples from 20 eyes were collected at the time of vitrectomy, and vascular endothelial growth factor levels were determined by using a time-resolved immunofluorometric assay. Vitreous vascular endothelial growth factor levels were significantly higher in eyes with proliferative diabetic retinopathy than in eyes without proliferative diabetic retinopathy (P = .006; Wilcoxon Rank Sum Test). The median vitreous concentration in the eyes with proliferative diabetic retinopathy was 29.1 pM and exceeded the known concentration required for the maximal proliferation of vascular endothelial cells in vitro. These data are consistent with vascular endothelial growth factor serving as a physiologically relevant angiogenic factor in proliferative diabetic retinopathy.

References (25)

  • KeckP.J. et al.

    Vascular permeability factor, an endothelial mitogen related to PDGF

    Science

    (1989)
  • LeungD.W. et al.

    Vascular endothelial growth factor is a secreted angiogenic mitogen

    Science

    (1989)
  • Cited by (1241)

    View all citing articles on Scopus

    This study was supported in part by research grant EY00325 from the National Institutes of Health (Dr. Adamis); and by the Beth Israel Pathology Foundation, Inc. (Drs. T.-K. Yeo and K.-T. Yeo). This study was presented in part at the Annual meeting of the Association for Research in Vision and Ophthalmology, Sarasota, Florida, May 4, 1994.

    Reprint requests to Anthony P. Adamis, M.D., Massachusetts Eye and Ear Infirmary, 243 Charles St., Boston, MA 02114.

    View full text